Specific Original Articles on Diabetes
Effects of miR-141 silencing on renal tubular epithelial cell damage induced by high glucose and Sirt1/Nrf2 signaling pathway
Yao Jianping, Ning Jianwen, Zhong Xiaojing, Jin Yueping, Qiu Wei
Published 2021-06-25
Cite as Chin J Endocr Surg, 2021, 15(3): 225-229. DOI: 10.3760/cma.j.cn.115807-20201214-00394
Abstract
ObjectiveTo investigate the effect of miR-141 down-regulation on the damage of renal tubular epithelial cell, and further to explore its mechanism.
MethodsThe renal tubular epithelial cell line HK-2 cells were divided into normal (5.5 mmol/L D-glucose) group, hypertonic group, high glucose (30 mmol/L D-glucose) group, negative control+high glucose group (transfected with NC inhibitor vector) and si-miR-141+high glucose group (transfected with miR-141 inhibitor vector) . Real time quantitative polymerase chain reaction (qRT-PCR) was used to detect the relative expression of miR-141. The production of reactive oxygen species (ROS) , cell viability and apoptosis were detected by DCFH-DA fluorescence staining, CCK-8 method and flow cytometry. The expression of Sirt1/Nrf2 signaling pathway related proteins was detected by Western blot. Luciferase reporter gene assay verified the targeting relationship between miR-141 and Sirt1 mRNA.
Results①Compared with the normal group, after transfection with si-miR-141, the relative expression of miR-141 decreased (1.00±0.03 vs 0.52±0.06) , the difference was statistically significant (F=278.104, P<0.05) ; ② Compared with the normal group [DCFH-DA fluorescence intensity (7.18±0.59) %], the high glucose group [DCFH-DA fluorescence intensity (84.95±3.21) %] cell ROS level was significantly increased, and compared with the high glucose group [DCFH-DA fluorescence intensity (84.95±3.21) %] Compared with the si-miR-141+ high glucose group [DCFH-DA fluorescence intensity (45.10±4.29) %] cell ROS levels were significantly reduced, the difference was statistically significant (allP<0.05) ; ③compared with the normal group (5.13%±0.78) % Compared with the hypertonic group (5.96±0.81) %, the high glucose group (32.76±2.95) % cell apoptosis rate was significantly increased, while the si-miR-141+ high glucose group (17.54%± 2.79) % apoptosis rate was significantly lower in the higher glucose group and the negative control+ high glucose group (33.40%±3.14) %, the difference was statistically significant (F=221.419, P<0.05) ; ④compared with the normal group (100±3.98) % Compared with the hypertonic group (95.68±5.14) %, the high glucose group (67.24±5.18) % HK-2 cell survival rate was significantly reduced; at the same time, compared with the high glucose group (67.24±5.18) % and Compared with the negative control+ high glucose group (65.33±3.10) %, the si-miR-141+ high glucose group (83.55±5.10) % cell survival rate increased significantly, and the difference was statistically significant (F=93.008, P<0.05) ; ⑤ Compared with the normal group and the hypertonic group, the expression of Cleaved Caspase 3 protein in the high glucose group increased, while the expression of Sirt1, Nrf2 and HO-1 protein was down-regulated; however, compared with the high glucose group, si- In the miR-141+ high glucose group, Cleaved caspase 3 protein expression decreased, while Sirt1, Nrf2 and HO-1 protein expression increased, the difference was statistically significant (allP<0.05) .
ConclusionsDown-regulation of miR-141 can ameliorate high glucose-induced renal tubular epithelial cell damage induced oxidative stress by activating Sirt1/Nrf2 signaling pathway.
Key words:
miR-141; Sirt1/Nrf2 pathway; Diabetic nephropathy; Oxidative stress; Apoptosis
Contributor Information
Yao Jianping
Department of Endocrinology, Huzhou Central Hospital, Huzhou Normal University Affiliated Central Hospital, Medical College of Zhejiang University, Huzhou 313000, China
Ning Jianwen
First Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310000, China
Zhong Xiaojing
Department of Endocrinology, Huzhou Central Hospital, Huzhou Normal University Affiliated Central Hospital, Medical College of Zhejiang University, Huzhou 313000, China
Jin Yueping
Department of Endocrinology, Huzhou Central Hospital, Huzhou Normal University Affiliated Central Hospital, Medical College of Zhejiang University, Huzhou 313000, China
Qiu Wei
Department of Endocrinology, Huzhou Central Hospital, Huzhou Normal University Affiliated Central Hospital, Medical College of Zhejiang University, Huzhou 313000, China